TrialThe oncologist2015

Phase I/II Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers.

Keith T Flaherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.